Hikma Pharmaceuticals PLC

LSE:HIK.L

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

Location

United Kingdom

Market Cap

USD 5.78 B

Share Price

USD 26.04

Avg Daily Volume

571,766

Change (1 day)

-1.36%

Change (1 year)

6.40%

Change (YTD)

4.44%

Hikma Pharmaceuticals PLC Return on Assets (ROA) for the year ending December 31, 2024: 6.99%

Hikma Pharmaceuticals PLC Return on Assets (ROA) is 6.99% for the year ending December 31, 2024, a 72.27% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

Hikma Pharmaceuticals PLC Return on Assets (ROA) for the year ending December 31, 2023 was 4.06%, a -3.45% change year over year.
Hikma Pharmaceuticals PLC Return on Assets (ROA) for the year ending December 31, 2022 was 4.20%, a -56.33% change year over year.
Hikma Pharmaceuticals PLC Return on Assets (ROA) for the year ending December 31, 2021 was 9.63%, a -7.62% change year over year.
Hikma Pharmaceuticals PLC Return on Assets (ROA) for the year ending December 31, 2020 was 10.42%, a -15.71% change year over year.